Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-26 @ 3:18 PM
NCT ID: NCT07329751
Eligibility Criteria: Eligibility Criteria Inclusion Criteria: Age between 18 and 70 years Right-handed Native Chinese speakers Clinical diagnosis of post-stroke aphasia caused by ischemic stroke, confirmed by CT or MRI Diagnosis of non-fluent aphasia based on the Western Aphasia Battery (WAB), with BDAE severity rating of 1-5 Time since stroke onset ≥ 2 weeks Stable vital signs, clear consciousness, and no severe cognitive impairment Ability to understand the study procedures and provide written informed consent (or consent provided by a legally authorized representative) Exclusion Criteria: History of aphasia or neurological disease not caused by stroke (e.g., traumatic brain injury, brain tumor, neurodegenerative diseases) Severe visual or auditory impairments that would interfere with task performance Severe cognitive impairment or disorders of consciousness preventing cooperation with language assessment or intervention Severe dysarthria or apraxia of speech that precludes valid language assessment History of epilepsy or other severe neurological conditions Severe systemic diseases (e.g., severe cardiopulmonary dysfunction, renal failure, hepatic failure, malignancy) Psychiatric disorders (e.g., schizophrenia, severe depression, or other major psychiatric illnesses) Contraindications to MRI or fNIRS assessment (e.g., metallic implants, severe claustrophobia)
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT07329751
Study Brief:
Protocol Section: NCT07329751